Published in Vaccine Weekly, February 5th, 2003
"Such data may be important for accurate planning and interpretation of studies of MBL and disease," said R. M. Minchinton and collaborators at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-02-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.